Regulatory & Compliance

Balancing Training and Clinical Duties in HSE Consultants
Management & Regulatory Balancing Training and Clinical Duties in HSE Consultants

Navigating the intricate landscape of healthcare demands more than just clinical expertise, as illustrated by the Health Service Executive (HSE) consultants grappling with the dual demands of stringent training requirements and clinical obligations. This challenge was vividly brought to light

Can Sterile Packaging Keep Pace with Healthcare Demands?
Management & Regulatory Can Sterile Packaging Keep Pace with Healthcare Demands?

The burgeoning demands of the healthcare industry have put the spotlight on sterile packaging, a pivotal element in ensuring the safety and efficacy of medical products and devices. As healthcare facilities worldwide grapple with escalating cases of chronic diseases, the need for impeccable

Why Are Clinical Trials Key to Medical Advances at UAMS?
Management & Regulatory Why Are Clinical Trials Key to Medical Advances at UAMS?

Clinical trials stand as a cornerstone in the journey toward medical advancements, acting as the bridge that connects theoretical research with practical, patient-centered care. At the University of Arkansas for Medical Sciences (UAMS), clinical trials are a celebrated and integral part of

AHA Urges Reforms to Address Insurers' Market Dominance
Management & Regulatory AHA Urges Reforms to Address Insurers' Market Dominance

The American Hospital Association (AHA) has put forth a series of recommendations aimed at reforming policies to mitigate health insurers' growing dominance in the market, focusing on recent developments that exacerbate competition challenges. The AHA has submitted these recommendations to the

FDA Approves First Blood Test for Early Alzheimer's Detection
Management & Regulatory FDA Approves First Blood Test for Early Alzheimer's Detection

In a significant advancement for Alzheimer's disease diagnosis, the US Food and Drug Administration (FDA) has approved a new and groundbreaking diagnostic tool, the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio blood test. Developed by Fujirebio Diagnostics, this test offers a less invasive and

Why is Nebraska's Medical Cannabis Bill Stalled?
Management & Regulatory Why is Nebraska's Medical Cannabis Bill Stalled?

The legislative process in Nebraska surrounding medical cannabis has been fraught with complexities, illustrating a profound disconnect between public opinion and political action. Despite overwhelming voter approval in recent elections, Legislative Bill 677, aimed at providing a regulatory

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later